TY - JOUR T1 - LAck of effect of treatment for helicobacter pylori on symptoms of nonulcer dyspepsia AU - Greenberg PD, Cello JP Y1 - 1999/10/01 N1 - 10.1001/archinte.159.19.2283 JO - Archives of Internal Medicine SP - 2283 EP - 2288 VL - 159 IS - 19 N2 - Background  Prior studies have yielded conflicting results on whether or not Helicobacter pylori causes nonulcer dyspepsia.Patients and Methods  We enrolled 100 consecutive patients with nonulcer dyspepsia into a randomized, double-blind, placebo-controlled trial. Patients with peptic ulcer disease, esophagitis, hepatobiliary disease, irritable bowel disease, or predominantly reflux-related symptoms were excluded by history and upper endoscopy. Helicobacter pylori infection was determined by biopsy and histologic examination. Serum H pylori IgG antibodies and CagA status were determined by Western blot. Enrolled patients were randomized to a 14-day regimen of omeprazole (20 mg twice daily) and clarithromycin (500 mg three times daily) or placebo. Dyspeptic symptoms were assessed by use of a visual analog scale at baseline and at 1, 3, 6, and 12 months after treatment. Follow-up upper endoscopy with biopsy was performed 4 weeks after treatment. Compliance was measured by tablet counts.Results  At 1 year, the change in dyspeptic symptoms was −24.0 (95% confidence interval, −69.0 to 21.0) in the omeprazole and clarithromycin group and −24.2 in the placebo group (95% confidence interval, −70.0 to 21.6). Furthermore, patients with persistent H pylori infection demonstrated a greater, but not significant, improvement in symptoms (−40±144 [mean±SD], −65±142, −45±138, and −39±163) than those with successful eradication (−26±126, −26±148, −12±126, and −25±151) at months 1, 3, 6, and 12, respectively.Conclusion  Patients with nonulcer dyspepsia should not routinely be treated for H pylori, since it is not a cause of this condition in most patients. SN - 0003-9926 M3 - doi: 10.1001/archinte.159.19.2283 UR - http://dx.doi.org/10.1001/archinte.159.19.2283 ER -